The Plasmodium sporozoite survives RTS,S vaccination

Trends in Parasitology

Volumn 21, Issue 10, 2005, Pages 456-461

  Snounou, Georges ^a   Grüner, Anne Charlotte ^b   Müller Graf, Christine D M ^c   Mazier, Dominique ^d   Rénia, Laurent ^b  

^a MUSÉUM NATIONAL D'HISTOIRE NATURELLE   (France)

^b INSTITUT COCHIN   (France)

^c Laboratoire de Parasitologie Evolutive CNRS UMR 7103 UFR 927   (France)

^d PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

MALARIA VACCINE;

CLINICAL TRIAL; HUMAN; INCIDENCE; MALARIA; PLASMODIUM FALCIPARUM; PROPHYLAXIS; REVIEW; TREATMENT OUTCOME; UNITED KINGDOM; VACCINATION;

PLASMODIUM FALCIPARUM;

EID: 24744453491     PISSN: 14714922     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pt.2005.08.002     Document Type: Article

References (37)

1. E. Sergent, and E. Sergent Sur l'immunité dans le paludisme des oiseaux. Conservation in vitro des sporozoïtes de Plasmodium relictum. Immunité relative obtenue par inoculation de ces sporozoïtes C.R. Hebd. Seances Acad. Sci. 151 1910 407 408
2. H.W. Mulligan Active immunization of fowls against Plasmodium gallinaceum by injection of killed homologous sporozoites J. Mal. Inst. India 4 1941 25 34
3. P.F. Russell Active immunization of fowls against sporozoites but not trophozoites of Plasmodium gallinaceum by injections of homologous sporozoites J. Mal. Inst. India 4 1942 311 319
4. W.H.G. Richards Active immunization of chicks against Plasmodium gallinaceum by inactivated homologous sporozoites and erythrocytic parasites Nature 212 1966 1492 1494
5. R.S. Nussenzweig Protective immunity produced by the injection of x-irradiated sporozoites of Plasmodium berghei Nature 216 1967 160 162
6. S.L. Hoffman Protection of humans against malaria by immunization with radiation-attenuated Plasmodium falciparum sporozoites J. Infect. Dis. 185 2002 1155 1164
7. V. Nussenzweig, and R.S. Nussenzweig Rationale for the development of an engineered sporozoite malaria vaccine Adv. Immunol. 45 1989 283 334
8. J. Ellis Cloning and expression in E. coli of the malarial sporozoite surface antigen gene from Plasmodium knowlesi Nature 302 1983 536 538
9. W.R. Ballou Safety and efficacy of a recombinant DNA Plasmodium falciparum sporozoite vaccine Lancet 1 1987 1277 1281
10. D.A. Herrington Safety and immunogenicity in man of a synthetic peptide malaria vaccine against Plasmodium falciparum sporozoites Nature 328 1987 257 259
11. D.M. Gordon Safety, immunogenicity, and efficacy of a recombinantly produced Plasmodium falciparum circumsporozoite protein-hepatitis B surface antigen subunit vaccine J. Infect. Dis. 171 1995 1576 1585
12. J.A. Stoute A preliminary evaluation of a recombinant circumsporozoite protein vaccine against Plasmodium falciparum malaria. RTS,S Malaria Vaccine Evaluation Group N. Engl. J. Med. 336 1997 86 91
13. K.A. Bojang Efficacy of RTS,S/AS02 malaria vaccine against Plasmodium falciparum infection in semi-immune adult men in The Gambia: a randomised trial Lancet 358 2001 1927 1934
14. P.L. Alonso Efficacy of the RTS,S/AS02A vaccine against Plasmodium falciparum infection and disease in young African children: randomised controlled trial Lancet 364 2004 1411 1420
15. P.G. Smith, and P.J. Milligan Malaria vaccine: 3 or 6 month's protection Lancet 365 2005 472 473
16. D.L. Medica, and P. Sinnis Quantitative dynamics of Plasmodium yoelii sporozoite transmission by infected anopheline mosquitoes Infect. Immun. 73 2005 4363 4369
17. R. Rosenberg An estimation of the number of malaria sporozoites ejected by a feeding mosquito Trans. R. Soc. Trop. Med. Hyg. 84 1990 209 212
18. + T-cell immune response to a conserved epitope in the circumsporozoite protein correlates with protection from natural Plasmodium falciparum infection and disease Nat. Med. 10 2004 406 410
19. + T cells producing IFN-γ J. Immunol. 171 2003 6961 6967
20. A.K. Nüssler In vivo induction of the nitric oxide pathway in hepatocytes after injection with irradiated malaria sporozoites, malaria blood parasites or adjuvants Eur. J. Immunol. 23 1993 882 887
21. J.R. Glynn Infecting dose and severity of falciparum malaria Trans. R. Soc. Trop. Med. Hyg. 89 1995 281 283
22. N.H. Fairley Sidelights on malaria in man obtained by subinoculation experiments Trans. R. Soc. Trop. Med. Hyg. 40 1947 621 676
23. B. Greenwood Why do some African children develop severe malaria? Parasitol. Today 7 1991 277 281
24. K.N. Brown, and I.N. Brown Immunity to malaria: antigenic variation in chronic infections of Plasmodium knowlesi Nature 208 1965 1286 1288
25. X-Z. Su The large diverse gene family var encodes proteins involved in cytoadherence and antigenic variation of Plasmodium falciparum-infected erythrocytes Cell 82 1995 89 100
26. H-P. Beck Analysis of multiple Plasmodium falciparum infections in Tanzanian children during the phase III trial of the malaria vaccine SPf66 J. Infect. Dis. 175 1997 921 926
27. G. Snounou Biased distribution of msp1 and msp2 allelic variants in Plasmodium falciparum populations in Thailand Trans. R. Soc. Trop. Med. Hyg. 93 1999 369 374
28. A. Alloueche Protective efficacy of the RTS,S/AS02 Plasmodium falciparum malaria vaccine is not strain specific Am. J. Trop. Med. Hyg. 68 2003 97 101
29. J.R. Glynn Impregnated bednets and the dose-severity relationship in malaria Parasitol. Today 10 1994 279 281
30. E. Belnoue Protective T cell immunity against malaria liver stage after vaccination with live sporozoites under chloroquine treatment J. Immunol. 172 2004 2487 2495
31. C. Ocana-Morgner Malaria blood stage suppression of liver stage immunity by dendritic cells J. Exp. Med. 197 2003 143 151
32. D.G. Heppner Jr Towards an RTS,S-based, multi-stage, multi-antigen vaccine against falciparum malaria: progress at the Walter Reed Army Institute of Research Vaccine 23 2005 2243 2250
33. K.E. Kester Efficacy of recombinant circumsporozoite protein vaccine regimens against experimental Plasmodium falciparum malaria J. Infect. Dis. 183 2001 640 647
34. J.A. Stoute Long-term efficacy and immune responses following immunization with the RTS,S malaria vaccine J. Infect. Dis. 178 1998 1139 1144
35. G. Pringle A quantitative study of naturally-acquired malaria infections in Anopheles gambiae and Anopheles funestus in a highly malarious area of East Africa Trans. R. Soc. Trop. Med. Hyg. 60 1966 626 632
36. P. Bejon Calculation of liver-to-blood inocula, parasite growth rates, and preerythrocytic vaccine efficacy, from serial quantitative polymerase chain reaction studies of volunteers challenged with malaria sporozoites J. Infect. Dis. 191 2005 619 626
37. C.C. Hermsen Testing vaccines in human experimental malaria: statistical analysis of parasitemia measured by a quantitative real-time polymerase chain reaction Am. J. Trop. Med. Hyg. 71 2004 196 201